CYCN CIK: 1755237

Korsana Biosciences, Inc. (CYCN)

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
55.5
FY22:
14.8
FY23:
8.02
FY24:
4.23
FY25:
4.64
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.87
FY22:
3.26
FY23:
5.35
FY24:
5.35
FY25:
5.35
Total assets
Change from FY21 to FY25
millions USD
FY21:
59.3
FY22:
18.1
FY23:
13.4
FY24:
9.58
FY25:
9.99

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
11.1
FY22:
7.63
FY23:
2.09
FY24:
0.73
FY25:
0.90
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
48.2
FY22:
10.5
FY23:
11.3
FY24:
8.85
FY25:
9.09
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
59.3
FY22:
18.1
FY23:
13.4
FY24:
9.58
FY25:
9.99

All amounts in millions USD Data sources:SEC EDGARTwelve Data